Revvity Sets Investor Day for November 13, 2026

  • Revvity (NYSE: RVTY) will host its 2026 Investor Day on November 13, 2026, at 9:00 a.m. ET.
  • Senior management will present updates on key business initiatives, operational achievements, and financial outlook.
  • Revvity reported 2025 revenue of $2.9 billion with approximately 11,000 employees.
  • The event will be webcasted, with a replay available post-event on the Investor Relations website.

Revvity’s Investor Day comes at a critical juncture as the company seeks to solidify its position in the healthcare and biotechnology sectors. With a focus on translational multi-omics technologies and biomarker identification, Revvity is navigating a landscape where innovation and operational efficiency are key drivers of growth. The event will provide insights into how the company plans to leverage its $2.9 billion revenue base and 11,000-strong workforce to maintain its competitive edge.

Financial Guidance
How Revvity’s updated financial outlook will reflect its strategic priorities and market positioning.
Operational Efficiency
Whether the company’s operational achievements align with its revenue growth targets.
Market Positioning
The pace at which Revvity can sustain its leadership in health science solutions amid industry competition.